Sensus Healthcare Plunges 21.5% on Q2 Loss, Revenue Drop

On August 8, 2025, Sensus Healthcare experienced a significant drop of 21.5% in pre-market trading, marking a notable decline in its stock performance.

Sensus Healthcare reported a quarterly loss of $0.06 per share for the second quarter of 2025, falling short of the estimated $0.01 per share. This financial setback was accompanied by a 20.7% decline in revenue compared to the same period in 2024, with Q2 2025 revenue totaling $7.3 million, significantly below the $9.3 million estimate.

The company's adjusted EBITDA for the quarter was negative $1.8 million, further highlighting the financial challenges faced by Sensus Healthcare. Despite these setbacks, analysts remain cautiously optimistic about the company's long-term prospects, particularly in the non-invasive skin cancer treatment market.